PAM
NVCR icon

Panagora Asset Management’s NovoCure NVCR Stock Holding History

Panagora Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.19M Buy
540,687
+463,565
+601% +$7.01M 0.03% 365
2026
Q1 		$841K Buy
+77,122
New +$963K ﹤0.01% 751
2025
Q3 		– Sell
-83,324
Closed -$1.48M – 1222
2025
Q2 		$1.48M Hold
83,324
– – 0.01% 548
2025
Q1 		$1.48M Sell
83,324
-97,592
-54% -$2.22M 0.01% 584
2024
Q4 		$5.39M Sell
180,916
-168,895
-48% -$3.57M 0.02% 329
2024
Q3 		$5.47M Sell
349,811
-59,983
-15% -$1.09M 0.03% 331
2024
Q2 		$7.02M Buy
409,794
+309,805
+310% +$5.45M 0.04% 266
2024
Q1 		$1.56M Buy
+99,989
New +$1.47M 0.01% 654
2023
Q3 		– Sell
-18,503
Closed -$768K – 1286
2023
Q2 		$768K Buy
18,503
+6,615
+56% +$411K ﹤0.01% 869
2023
Q1 		$715K Sell
11,888
-214
-2% -$17.1K ﹤0.01% 966
2022
Q4 		$888K Sell
12,102
-600
-5% -$45.1K 0.01% 936
2022
Q3 		$965K Hold
12,702
– – 0.01% 872
2022
Q2 		$883K Hold
12,702
– – 0.01% 928
2022
Q1 		$1.05M Buy
12,702
+9,366
+281% +$690K 0.01% 914
2021
Q4 		$250K Sell
3,336
-868
-21% -$87.1K ﹤0.01% 1424
2021
Q3 		$488K Hold
4,204
– – ﹤0.01% 1322
2021
Q2 		$933K Sell
4,204
-477
-10% -$92.8K 0.01% 1026
2021
Q1 		$619K Sell
4,681
-8,551
-65% -$1.35M ﹤0.01% 1230
2020
Q4 		$2.29M Buy
13,232
+3,288
+33% +$450K 0.01% 656
2020
Q3 		$1.11M Buy
9,944
+193
+2% +$15.4K 0.01% 871
2020
Q2 		$578K Sell
9,751
-63,309
-87% -$4.16M ﹤0.01% 1146
2020
Q1 		$4.92M Sell
73,060
-27,711
-27% -$2.19M 0.03% 352
2019
Q4 		$8.49M Buy
100,771
+93,520
+1,290% +$7.55M 0.04% 363
2019
Q3 		$542K Buy
+7,251
New +$580K ﹤0.01% 1259
2017
Q3 		– Sell
-1,830
Closed -$32K – 2444
2017
Q2 		$32K Buy
+1,830
New +$23.6K ﹤0.01% 2159

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Panagora Asset Management's NVCR Position: Q2 2026 in Review

Panagora Asset Management increased its NovoCure (NVCR) stake by 601% in Q2 2026, buying an estimated $7.01M and bringing the position to 540,687 shares worth $8.19M. The position accounts for 0.03% of the portfolio, ranked #365.

Panagora Asset Management first reported a position in NVCR in Q2 2017 and has held it in 25 quarters since. The position peaked at $8.49M in Q4 2019. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Panagora Asset Management held 540,687 shares of NovoCure worth $8.19M as of Q2 2026.
  • Panagora Asset Management bought 463,565 NovoCure shares in Q2 2026, an estimated $7.01M.
  • NovoCure made up 0.03% of Panagora Asset Management's portfolio in Q2 2026, its #365 holding.
  • Panagora Asset Management first reported a position in NovoCure in Q2 2017 and has held it in 25 quarters since.
  • Panagora Asset Management's NovoCure position peaked at $8.49M in Q4 2019.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.